Stifel Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. CRWD
4. AVGO
5. ULTA
6. GTLB
7. USO
8. MDT
9. GOOGL
10. VRTS

Go back to Stifel Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)
(NASDAQ: KALV) Delayed: 26.95 --0 (-0%)
Previous Close $26.95    52 Week High $ 
Open $26.95    52 Week Low $ 
Day High $26.95    P/E N/A 
Day Low $26.95    EPS $ 
Volume 119,129